… with Refractory DLBCL! About 40 participants gathered in the NAU Vintage Hotel Lisboa to assess and discuss this hot topic. See programme here. The Wednesday afternoon was dedicated to the “Definition, biology and prognosis” of Refractory DLBCL with a … Continue reading
‘‘A Joint Effort to bring Lymphoma Research forward’’
Lymphoma, the sixth cancer worldwide in terms of incidence, is a complex disease. ELI, The European Lymphoma Institute, regroups top European specialists in the field of lymphoma within a net dedicated to research, training and education. To date, thirteen European academic research groups have come together in an effort to define strategies to analyse and characterize this cancer, common diagnostic procedures and therapeutic standards as well as to facilitate clinical and fundamental research at the European level.
As a result of this collaborative work, truly unique in the world, together we are helping to bring lymphoma research forward, and to guarantee equal access for all patients to the best possible care.
Download ELI’s brochure (in English)